We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

BioFocus and Usher III Initiative, Inc. Announce Collaboration

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
BioFocus and the Usher III Initiative, Inc., a not-for-profit organization, announced that they have embarked on a drug discovery project focused on Usher Syndrome Type III.

Usher Syndrome is a rare genetic disorder that causes the loss of hearing and vision. Under the agreement, BioFocus will perform an integrated program encompassing medicinal chemistry and biological sciences.

“We are pleased to support the Usher III Initiative in its aim to find a targeted treatment and cure for Usher III,” said Angus MacLeod, Vice President, Medicinal Chemistry, BioFocus. “This collaboration will utilize BioFocus’ expertise in integrated drug discovery programs.”